Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124161732 | 12416173 | 2 | F | 20130605 | 20160810 | 20160530 | 20160818 | PER | US-TAKEDA-TPA2013A05386 | TAKEDA | 66.54 | YR | F | Y | 59.87000 | KG | 20160818 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124161732 | 12416173 | 1 | PS | PREVACID SOLUTAB | LANSOPRAZOLE | 1 | Oral | 30 MG, QD | UNKNOWN | 21428 | 30 | MG | ORODISPERSIBLE TABLET | QD | |||||
| 124161732 | 12416173 | 2 | SS | PREVACID SOLUTAB | LANSOPRAZOLE | 1 | 21428 | ORODISPERSIBLE TABLET | |||||||||||
| 124161732 | 12416173 | 3 | SS | AMLODIPINE BESILATE | AMLODIPINE BESYLATE | 1 | Unknown | 5 MG, UNK | Y | UNKNOWN | 0 | 5 | MG | TABLET | |||||
| 124161732 | 12416173 | 4 | SS | AMLODIPINE BESILATE | AMLODIPINE BESYLATE | 1 | Unknown | 5 MG, QD | Y | UNKNOWN | 0 | 5 | MG | TABLET | QD | ||||
| 124161732 | 12416173 | 5 | SS | AMLODIPINE BESILATE | AMLODIPINE BESYLATE | 1 | Unknown | 2.5 MG, UNK | Y | UNKNOWN | 0 | 2.5 | MG | TABLET | |||||
| 124161732 | 12416173 | 6 | SS | AMLODIPINE BESILATE | AMLODIPINE BESYLATE | 1 | Unknown | 2.5 MG, QD | Y | UNKNOWN | 0 | 2.5 | MG | TABLET | QD | ||||
| 124161732 | 12416173 | 7 | SS | AMLODIPINE BESILATE | AMLODIPINE BESYLATE | 1 | Unknown | 2.5 MG, BID | Y | UNKNOWN | 0 | 2.5 | MG | TABLET | BID | ||||
| 124161732 | 12416173 | 8 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 75 ?G, QD | U | 0 | 75 | UG | QD | |||||||
| 124161732 | 12416173 | 9 | C | TOPROL XL | METOPROLOL SUCCINATE | 1 | UNK, QD | U | 0 | TABLET | QD | ||||||||
| 124161732 | 12416173 | 10 | C | TOPROL XL | METOPROLOL SUCCINATE | 1 | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124161732 | 12416173 | 1 | Gastrooesophageal reflux disease |
| 124161732 | 12416173 | 2 | Oesophagitis |
| 124161732 | 12416173 | 3 | Hypertension |
| 124161732 | 12416173 | 8 | Autoimmune thyroiditis |
| 124161732 | 12416173 | 9 | Hypertension |
| 124161732 | 12416173 | 10 | Heart rate irregular |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124161732 | 12416173 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124161732 | 12416173 | Dehydration | |
| 124161732 | 12416173 | Dental caries | |
| 124161732 | 12416173 | Dysphagia | |
| 124161732 | 12416173 | Gingival disorder | |
| 124161732 | 12416173 | Hypotension | |
| 124161732 | 12416173 | Osteoporosis | |
| 124161732 | 12416173 | Tooth loss | |
| 124161732 | 12416173 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124161732 | 12416173 | 1 | 201206 | 0 | ||
| 124161732 | 12416173 | 4 | 2014 | 0 | ||
| 124161732 | 12416173 | 5 | 20150108 | 0 | ||
| 124161732 | 12416173 | 6 | 20150108 | 0 | ||
| 124161732 | 12416173 | 7 | 20160108 | 0 | ||
| 124161732 | 12416173 | 9 | 20090409 | 0 |